The added value of comorbidities in predicting survival in idiopathic pulmonary fibrosis: a multicentre observational study
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Background: The gender–age–physiology (GAP) model was developed to predict the risk of death. Comorbidities are common in idiopathic pulmonary fibrosis (IPF) and may impact on survival. We evaluated the ability of comorbidities to improve prediction of survival in IPF patients beyond the variables included in the GAP model. Methods: We developed a prediction model named TORVAN using data from two independent cohorts. Continuous and point-score prediction models were developed with estimation of full and sparse versions of both. Model discrimination was assessed using the C-index and calibrated by comparing predicted and observed cumulative mortality at 1–5 years. Results: Discrimination was similar for the sparse continuous model in the derivation and validation cohorts (C-index 71.0 versus 70.0, respectively), and significantly improved the performance of the GAP model in the validation cohort (increase in C-index of 3.8, p=0.001). In contrast, the sparse point-score model did not perform as well in the validation cohort (C-index 72.5 in the derivation cohort versus 68.1 in the validation cohort), but still significantly improved upon the performance of the GAP model (C-index increased by 2.5, p=0.037). Conclusions: The inclusion of comorbidities in TORVAN models significantly improved the discriminative performance in prediction of risk of death compared to GAP.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Different composite predictors of outcome have been developed in the past years; however, clinical uptake and external validation is limited.(226–232)”
From Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. (2021) · cites this paper as [226]
Citations
Cites
Miller, M. R., Hankinson, J., Brusasco, V., Burgos, F., Casaburi, R., Coates, A., Crapo, R., Enright, P., van der Grinten, C. P. M., Gustafsson, P., et al. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00034805 · Cited by 15,627
Raghu, G., Collard, H. R., Egan, J. J., Martinez, F. J., Behr, J., Brown, K. K., Colby, T. V., Cordier, J.-F., Flaherty, K. R., Lasky, J. A., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2009-040gl · Cited by 7,186
Self-citation2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Galiè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Vonk Noordegraaf, A., Beghetti, M., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv317 · Cited by 6,931
Galiè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Vonk Noordegraaf, A., Beghetti, M., et al. (2015) · European Respiratory Journal · doi:10.1183/13993003.01032-2015 · Cited by 3,172
Idiopathic Pulmonary Fibrosis: Diagnosis and Treatment: International Consensus Statement
(2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.2.ats3-00 · Cited by 2,628
Clinical course and prediction of survival in idiopathic pulmonary fibrosis
Ley, B., Collard, H. R., & King, T. E. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201006-0894ci · Cited by 1,765
Self-citationA Multidimensional Index and Staging System for Idiopathic Pulmonary Fibrosis
Ley, B., Ryerson, C. J., Vittinghoff, E., Ryu, J. H., Tomassetti, S., Lee, J. S., Poletti, V., Buccioli, M., Elicker, B. M., Jones, K. D., et al. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-156-10-201205150-00004 · Cited by 1,308
Self-citationPrognostic Significance of Histopathologic Subsets in Idiopathic Pulmonary Fibrosis
BJORAKER, J. A., RYU, J. H., EDWIN, M. K., MYERS, J. L., TAZELAAR, H. D., SCHROEDER, D. R., & OFFORD, K. P. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.1.9704130 · Cited by 1,039
Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity
Cottin, V., Nunes, H., Brillet, P.-Y., Delaval, P., Devouassoux, G., Tillie-Leblond, I., Israel-Biet, D., Court-Fortune, I., Valeyre, D., & Cordier, J.-F. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00021005 · Cited by 1,004
Prevalence and Outcomes of Pulmonary Arterial Hypertension in Advanced Idiopathic Pulmonary Fibrosis
Lettieri, C. J., Nathan, S. D., Barnett, S. D., Ahmad, S., & Shorr, A. F. (2006) · Chest · doi:10.1378/chest.129.3.746 · Cited by 879
Cited by
Raghu, G., Remy-Jardin, M., Richeldi, L., Thomson, C. C., Inoue, Y., Johkoh, T., Kreuter, M., Lynch, D. A., Maher, T. M., Martinez, F. J., et al. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202202-0399st · Cited by 2,957
Self-citationLeard, L. E., Holm, A. M., Valapour, M., Glanville, A. R., Attawar, S., Aversa, M., Campos, S. V., Christon, L. M., Cypel, M., Dellgren, G., et al. (2021) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2021.07.005 · Cited by 821
Self-citationThe therapy of idiopathic pulmonary fibrosis: what is next?
Somogyi, V., Chaudhuri, N., Torrisi, S. E., Kahn, N., Müller, V., & Kreuter, M. (2019) · European Respiratory Review · doi:10.1183/16000617.0021-2019 · Cited by 265
Self-citationProgression of fibrosing interstitial lung disease
Wong, A. W., Ryerson, C. J., & Guler, S. A. (2020) · Respiratory Research · doi:10.1186/s12931-020-1296-3 · Cited by 185
Comorbidities in idiopathic pulmonary fibrosis: an underestimated issue
Caminati, A., Lonati, C., Cassandro, R., Elia, D., Pelosi, G., Torre, O., Zompatori, M., Uslenghi, E., & Harari, S. A. (2019) · European Respiratory Review · doi:10.1183/16000617.0044-2019 · Cited by 139
Althobiani, M. A., Russell, A., Jacob, J., Ranjan, Y., Folarin, A., Hurst, J. R., & Porter, J. C. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1296890 · Cited by 148
Baseline characteristics and comorbidities in the CAnadian REgistry for Pulmonary Fibrosis
Fisher, J. H., Kolb, M. R. J., Algamdi, M., Morisset, J., Johannson, K. A., Shapera, S., Wilcox, P., To, T. M., Sadatsafavi, M., Manganas, H., et al. (2019) · BMC Pulmonary Medicine · doi:10.1186/s12890-019-0986-4 · Cited by 106
Molecular Mechanisms and Cellular Contribution from Lung Fibrosis to Lung Cancer Development
Samarelli, A. V., Masciale, V., Aramini, B., Coló, G. P., Tonelli, R., Marchioni, A., Bruzzi, G., Gozzi, F., Andrisani, D., Castaniere, I., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212179 · Cited by 99
Faverio, P., Bocchino, M., Caminati, A., Fumagalli, A., Gasbarra, M., Iovino, P., Petruzzi, A., Scalfi, L., Sebastiani, A., Stanziola, A. A., et al. (2020) · Nutrients · doi:10.3390/nu12041131 · Cited by 80
for the EMPIRE registry, Tran, T., Šterclová, M., Moğulkoç, N., Lewandowska, K. B., Müller, V., Hájková, M., Kramer, M. R., Jovanović, D., Tekavec-Trkanjec, J., et al. (2020) · Respiratory Research · doi:10.1186/s12931-019-1271-z · Cited by 79
Proinflammatory Cytokines in Chronic Respiratory Diseases and Their Management
Chavda, V. P., Bezbaruah, R., Ahmed, N., Alom, S., Bhattacharjee, B., Nalla, L. V., Rynjah, D., Gadanec, L. K., & Apostolopoulos, V. (2025) · Cells · doi:10.3390/cells14060400 · Cited by 67
Jovanović, D. M., Šterclová, M., Moğulkoç, N., Lewandowska, K. B., Müller, V., Hájková, M., Studnicka, M., Tekavec-Trkanjec, J., Littnerová, S., Vašáková, M., et al. (2022) · Respiratory Research · doi:10.1186/s12931-022-02033-6 · Cited by 57
Jouneau, S., Rousseau, C., Léderlin, M., Lescoat, A., Kerjouan, M., Chauvin, P., Paz, D. L., Guillot, S., Oger, E., Vernhet, L., et al. (2022) · Clinical Nutrition · doi:10.1016/j.clnu.2022.05.001 · Cited by 54
Bocchino, M., Zanotta, S., Capitelli, L., & Galati, D. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.664109 · Cited by 52
Cheng, X., Jiang, S., Pan, B., Xie, W., & Meng, J. (2023) · Lipids in Health and Disease · doi:10.1186/s12944-023-01964-3 · Cited by 43
Glaspole, I., Bonella, F., Bargagli, E., Glassberg, M. K., Caro, F. M., Stansen, W., Quaresma, M., Orsatti, L., & Bendstrup, E. M. (2021) · Respiratory Research · doi:10.1186/s12931-021-01695-y · Cited by 43
Torrisi, S. E., Kahn, N. C., Wälscher, J., Sarmand, N., Polke, M., Kehler, L., Eichinger, M., Heußel, C. P., Palmucci, S., Sambataro, F. M., et al. (2019) · BMC Pulmonary Medicine · doi:10.1186/s12890-019-0937-0 · Cited by 38
Self-citationDisease trajectories in interstitial lung diseases – data from the EXCITING-ILD registry
Buschulte, K., Kabitz, H., Hagmeyer, L., Hammerl, P., Esselmann, A., Wiederhold, C., Skowasch, D., Stolpe, C., Joest, M., Veitshans, S., et al. (2024) · Respiratory Research · doi:10.1186/s12931-024-02731-3 · Cited by 34
Self-citationPredictive biomarkers of disease progression in idiopathic pulmonary fibrosis
Zhu, W., Liu, C., Tan, C., & Zhang, J. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e23543 · Cited by 32
Caminati, A., Madotto, F., Conti, S., Cesana, G., Mantovani, L. G., & Harari, S. A. (2021) · Internal and Emergency Medicine · doi:10.1007/s11739-021-02651-w · Cited by 33
Phase angle in assessment and monitoring treatment of individuals with respiratory disease
Benedetto, F. D., Marinari, S., & Blasio, F. D. (2023) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-023-09786-5 · Cited by 33
Shin, Y. J., Yun, G., Yoon, S. H., Song, H., Kim, J., Kim, J., Park, J. S., Lee, K. W., & Lee, K. H. (2021) · European Radiology · doi:10.1007/s00330-021-08038-x · Cited by 33
Evolution and treatment of idiopathic pulmonary fibrosis
Torrisi, S. E., Kahn, N. C., Vancheri, C., & Kreuter, M. (2020) · La Presse Médicale · doi:10.1016/j.lpm.2020.104025 · Cited by 29
Self-citationWalking the path of treatable traits in interstitial lung diseases
Amati, F., Spagnolo, P., Ryerson, C. J., Oldham, J. M., Gramegna, A., Stainer, A., Mantero, M., Sverzellati, N., Lacedonia, D., Richeldi, L., et al. (2023) · Respiratory Research · doi:10.1186/s12931-023-02554-8 · Cited by 24
Khor, Y. H., Goh, N. S. L., Wong, A. W., Johannson, K. A., Marcoux, V. S., Fisher, J. H., Assayag, D., Manganas, H., Khalil, N., Kolb, M. R. J., et al. (2022) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202108-980oc · Cited by 23
Pan, L., Lu, Y.-H., Li, Z., Tan, Y., Yang, H., Ruan, P., & Li, R. (2020) · Medical Science Monitor · doi:10.12659/msm.922634 · Cited by 23
Galati, D., Zanotta, S., Polistina, G. E., Coppola, A., Capitelli, L., & Bocchino, M. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108454 · Cited by 21
Walters, T. M., Leong, M. C. H., Montesi, S. B., Ryerson, C. J., & Khor, Y. H. (2025) · European Respiratory Review · doi:10.1183/16000617.0238-2024 · Cited by 20
Decoding the complexity: mechanistic insights into comorbidities in idiopathic pulmonary fibrosis
Selman, M., Buendia-Roldan, I., & Pardo, A. (2025) · European Respiratory Journal · doi:10.1183/13993003.02418-2024 · Cited by 20
Fernández‐Jiménez, R., César, E. C., García, A. S., Hernández, F. E., Vegas-Aguilar, I. M., Amaya-Campos, M. D. M., Cornejo-Pareja, I. M., Guirado-Peláez, P., Simón‐Frapolli, V. J., Murri, M., et al. (2023) · Nutrients · doi:10.3390/nu15204473 · Cited by 18
Moor, C. C., Tak, N. C., Owusuaa, C., Miedema, J., Baart, S. J., van der Rijt, C. C. D., & Wijsenbeek, M. S. (2021) · Respiration · doi:10.1159/000516291 · Cited by 18
Self-citationDynapenia is highly prevalent in older patients with advanced idiopathic pulmonary fibrosis
Bocchino, M., Alicante, P., Capitelli, L., Stanziola, A. A., Gallotti, L., Gregorio, A. D., Rea, G., Sanduzzi, A., & Scalfi, L. (2021) · Scientific Reports · doi:10.1038/s41598-021-97424-y · Cited by 19
Subclinical liver fibrosis in patients with idiopathic pulmonary fibrosis
Cocconcelli, E., Tonelli, R., Abbati, G., Marchioni, A., Castaniere, I., Pelizzaro, F., Russo, F. P., Vegetti, A., Balestro, E., Pietrangelo, A., et al. (2020) · Internal and Emergency Medicine · doi:10.1007/s11739-020-02376-2 · Cited by 17
Emerging roles of noncoding RNAs in idiopathic pulmonary fibrosis
Wang, H., Sun, K., Peng, H. F., Wang, Y., & Zhang, L. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-02170-5 · Cited by 17
Mondoni, M., Alfano, F., Varone, F., Muscato, G., Conti, C., Saderi, L., Chiesa, A., Marco, F. D., Vancheri, C., Richeldi, L., et al. (2022) · Respiration · doi:10.1159/000527308 · Cited by 16
Self-citationMalnutrition in idiopathic pulmonary fibrosis: the great forgotten comorbidity!
Jouneau, S., Léderlin, M., Vernhet, L., & Thibault, R. (2019) · European Respiratory Journal · doi:10.1183/13993003.00418-2019 · Cited by 16
González-García, M., Rincón-Álvarez, E., Alberti, M. L., Durán, M., Caro, F. M., Venero, M. D. C., Liberato-Salinas, Y., & Buendía-Roldán, I. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.679487 · Cited by 16
Liquid Biopsy Is a Promising Tool for Genetic Testing in Idiopathic Pulmonary Fibrosis
Pallante, P., Malapelle, U., Nacchio, M., Sgariglia, R., Galati, D., Capitelli, L., Zanotta, S., Galgani, M., Piemonte, E., Zamparelli, A. S., et al. (2021) · Diagnostics · doi:10.3390/diagnostics11071202 · Cited by 15
Stubbe, B., Ittermann, T., Grieger, A., Walther, C., Gläser, S., & Ewert, R. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11061609 · Cited by 13
Xiong, M., Wu, Z., Zhao, Y., Zhao, D. B., Pan, Z., Wu, X., Liu, W. Q., & Hu, K. (2023) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2023.04.008 · Cited by 13
Guenther, A., Tello, S., Schoppe, M. C., Pons‐Kühnemann, J., Seeger, W., Stiben, J., Tello, K., Molina‐Molina, M., Vancheri, C., Crestani, B., et al. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14207352 · Cited by 12
Self-citationBordas-Martínez, J., Gavaldà, R., Shull, J. G., Vicens‐Zygmunt, V., Planas‐Cerezales, L., Bermudo, G., Santos, S., Salord, N., Monasterio, C., Molina‐Molina, M., et al. (2021) · ERJ Open Research · doi:10.1183/23120541.00897-2020 · Cited by 11
Comparing effectiveness of prognostic tests in idiopathic pulmonary fibrosis
Moua, T., Lee, A. S., & Ryu, J. H. (2019) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2019.1656069 · Cited by 10
Pulmonary hypertension associated with interstitial lung disease: a state-of-the-art review
Raghu, G., Sahay, S., Price, L. C., Weatherald, J. C., Rayner, S. G., Behr, J., Boucly, A., Das, M., McLaughlin, V., Rahaghi, F., et al. (2026) · European Respiratory Journal · doi:10.1183/13993003.02651-2025 · Cited by 10
Bocchino, M., Bruzzese, D., Scioscia, G., Capitelli, L., Tondo, P., Rea, G., Barbaro, M. P. F., & Lacedonia, D. (2023) · Respiratory Medicine and Research · doi:10.1016/j.resmer.2023.101013 · Cited by 11
Pharmacological treatment in Idiopathic Pulmonary Fibrosis: current issues and future perspectives
Vancheri, C., Sciacca, E., Muscato, G., Spicuzza, L., Fruciano, M., Gili, E., Sambataro, G., Palmucci, S., & Libra, A. (2024) · Multidisciplinary Respiratory Medicine · doi:10.5826/mrm.2024.982 · Cited by 14
Self-citationComorbidities’ Effect on IPF: Pathogenesis and Management
Salotti, A., Chianese, M. I., Romallo, A., Nes, A. D., Angoni, D., Galantino, A., Chernovsky, M., Mondini, L., Salton, F., Confalonieri, P., et al. (2025) · Biomedicines · doi:10.3390/biomedicines13061362 · Cited by 9
Kette, S., Reccardini, N., Salton, F., Confalonieri, P., Andrisano, A. G., Chianese, M. I., Nes, A. D., Maggisano, M., Galantino, A., Nicolosi, S., et al. (2025) · Pharmaceuticals · doi:10.3390/ph18030411 · Cited by 8
Baig, S. H., & Yoo, E. J. (2024) · Life · doi:10.3390/life14010156 · Cited by 8
Coronary artery calcium score is a prognostic factor for mortality in idiopathic pulmonary fibrosis
Caminati, A., Zompatori, M., Fuccillo, N. R. T. D. A., Sonaglioni, A., Elia, D., Cassandro, R., Trevisan, R., Rispoli, A., Pelosi, G., & Harari, S. A. (2022) · Minerva Medica · doi:10.23736/s0026-4806.22.08018-1 · Cited by 8
Establishment and application of the BRP prognosis model for idiopathic pulmonary fibrosis
Cheng, X., Feng, Z., Pan, B., Liu, Q., Han, Y., Zou, L., Rong, P., & Meng, J. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04668-5 · Cited by 8
Zhou, M., Ouyang, J., Zhang, G., & Zhu, X. (2022) · BMC Pulmonary Medicine · doi:10.1186/s12890-022-02269-4 · Cited by 7
Mohamed, R., Sangani, R. G., Kamal, K. M., LeMaster, T. J., Rudisill, T. M., Scott, V., Kelley, G. A., & Wen, S. (2024) · Medicine Advances · doi:10.1002/med4.86 · Cited by 7
Machine Learning and BMI Improve the Prognostic Value of GAP Index in Treated IPF Patients
Lacedonia, D., Pace, C. C. D., Rea, G., Capitelli, L., Gallo, C., Scioscia, G., Tondo, P., & Bocchino, M. (2023) · Bioengineering · doi:10.3390/bioengineering10020251 · Cited by 7
Reply to: Malnutrition in idiopathic pulmonary fibrosis: the great forgotten comorbidity!
Torrisi, S. E., Ley, B., Kreuter, M., Wijsenbeek, M. S., Vittinghoff, E., Collard, H. R., & Vancheri, C. (2019) · European Respiratory Journal · doi:10.1183/13993003.00615-2019 · Cited by 7
Self-citationModified blood cell GAP model as a prognostic biomarker in idiopathic pulmonary fibrosis
Kreuter, M., Lee, J. S., Tzouvelekis, A., Oldham, J. M., Molyneaux, P. L., Weycker, D. A., Atwood, M., Samara, K. D., Kirchgässler, K.-U., & Maher, T. M. (2024) · ERJ Open Research · doi:10.1183/23120541.00666-2023 · Cited by 5
Self-citationZheng, Q., Cox, I. A., de Graaff, B., Campbell, J. A., Corte, T. J., Glaspole, I., Navaratnam, V. V., Hopkins, P. M.-A., Zappala, C. J., Ahmad, H., et al. (2022) · Quality of Life Research · doi:10.1007/s11136-022-03331-8 · Cited by 5
Zanini, U., Ding, J., Luppi, F., Kaur, K., Anzani, N., Franco, G., Ferrara, G., Kalluri, M., & Mura, M. (2024) · Lung · doi:10.1007/s00408-024-00748-5 · Cited by 5
Quality of life in idiopathic pulmonary fibrosis in Latin American countries
Aguilar‐Duran, H., Fernández, M., González-García, M., Rincón-Álvarez, E., Alberti, M. L., Caro, F. M., Tavera, E., Vásquez, E., Cortez, N., Salinas, M., et al. (2025) · BMC Pulmonary Medicine · doi:10.1186/s12890-025-03506-2 · Cited by 6
Zhu, W., Li, H., Li, Y., Sun, L., Kong, L., Ye, X., Cai, Q., & Lv, X. (2021) · BMC Pulmonary Medicine · doi:10.1186/s12890-021-01606-3 · Cited by 5
Moon, J. Y., Beenken, M. J., & Moua, T. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15031051 · Cited by 4
A Systematic Review of Mortality Risk Prediction Models for Idiopathic Pulmonary Fibrosis
Wu, Y., Li, P., Wang, M., Liu, Y., Leng, J., Li, X., Lv, X., Pang, L., & Zang, N. (2025) · British Journal of Hospital Medicine · doi:10.12968/hmed.2024.0934 · Cited by 4
Sonaglioni, A., Caminati, A., Elia, D., Trevisan, R., Zompatori, M., GRASSO, E., Lombardo, M., & Harari, S. A. (2023) · Minerva Medica · doi:10.23736/s0026-4806.23.08585-3 · Cited by 3
Fazlıoğlu, N., Sasanı, H., Fazlıoğlu, M., Çiftçi, E., & Mutlu, L. C. (2025) · BMC Pulmonary Medicine · doi:10.1186/s12890-025-03624-x · Cited by 3
Asthma exacerbation comorbidity index (AECI): Predicting in-hospital adverse outcomes
Zhao, C., Wang, G., Zhang, L., Wang, Q., Li, L., Liu, Y., Liu, L., Yuan, L., Feng, M., Wang, G., et al. (2025) · Respiratory Medicine · doi:10.1016/j.rmed.2025.108024 · Cited by 3
Yang, L., Tan, W., Zhang, Y., Cao, F., Wu, Z., Jiao, Y., & Niu, J. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1653435 · Cited by 4
Lang, D., Lamprecht, B., Moğulkoç, N., Šterclová, M., Lewandowska, K. B., Kramer, M. R., Bartos, V., Plačková, M., Müller, V., Ovesná, P., et al. (2026) · Annals of Medicine · doi:10.1080/07853890.2026.2616978 · Cited by 2
Shen, Q., Zhou, S., Ouyang, X., Tan, Y., Chen, S., Shi, J., & Peng, H. (2026) · Heart & Lung · doi:10.1016/j.hrtlng.2026.102812 · Cited by 2
Tienza, S. T., de Miguel‐Díez, J., Ortega, C., & Esteban, J. J. J. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15093421 · Cited by 1
Common Co-Morbidities in Fibrosing Interstitial Lung Disease
Kahn, N. C., Torrisi, S. E., Somogyi, V., & Kreuter, M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-08-102723-3.00019-6
Self-citationDi, J., Li, X., Yang, J., Li, L., & Yu, X. (2022) · Risk Management and Healthcare Policy · doi:10.2147/rmhp.s357606
Idiopathic pulmonary fibrosis: the risk of cancer and the impact on cancer care
Vancheri, C. (2022) · European Respiratory Society eBooks · doi:10.1183/2312508x.10019121
Self-citationАлексеевна, О. А., Куликов, А. Н., Rabik, Y. D., Butomo, M. I., Zinchenko, A. V., Markov, N. V., Zaripova, Z. A., Dzadzua, D., Obukhova, E. V., Ахминеева, А. Х., et al. (2024) · Regional blood circulation and microcirculation · doi:10.24884/1682-6655-2024-23-1-16-25
İdiyopatik Pulmoner Fibrozis Tanıdan Tedaviye Güncel Yaklaşım
Ölmez, H. (2025) · Akademisyen Kitabevi eBooks · doi:10.37609/akya.3774
Jovanovic, D. M., Šterclová, M., Moğulkoç, N., Lewandowska, K., Müller, V., Hájková, M., Studnicka, M., Tekavec-Trkanjec, J., Littnerová, S., & Vašáková, M. (2022) · Figshare · doi:10.6084/m9.figshare.19915356
Cheng, X., Feng, Z., Pan, B., Liu, Q., Han, Y., Zou, L., Rong, P., & Meng, J. (2023) · Figshare · doi:10.6084/m9.figshare.24548150
Glaspole, I., Bonella, F., Bargagli, E., Glassberg, M. K., Caro, F., Stansen, W., Quaresma, M., Orsatti, L., & Bendstrup, E. M. (2021) · Figshare · doi:10.6084/m9.figshare.14490373
Buschulte, K., Kabitz, H.-J., Hagmeyer, L., Hammerl, P., Esselmann, A., Wiederhold, C., Skowasch, D., Stolpe, C., Joest, M., Veitshans, S., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26689817
Self-citationZhao, X., Ding, W., Zhang, L., Cai, Q., Lu, Z., Huang, W., Xie, W., & Kong, H. (2026) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/0113862073468105260421052108
Tiede, R., Reichenberger, F., Fischinger, C., Schwaiblmair, M., Meyer, F. J., Benedikter, J., Popp, F., Dechant, C., Späthling‐Mestekemper, S., Thürmel, K., et al. (2026) · Respiration · doi:10.1159/000551381
Fatima, S. U. K., Jabber, A., Khanam, M. H., Khan, J., Talukder, M. M., & Hasnat, M. A. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261476085
Metadata
- Authors
- Torrisi, S. E., Ley, B., Kreuter, M., Wijsenbeek, M., Vittinghoff, E., Collard, H. R., & Vancheri, C.
- Affiliations
- University of Catania (IT)
- University of California, San Francisco (US)
- Heidelberg University (DE)
- Erasmus MC (NL)
- ORCID
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 2018-12-21
- Volume
- 53
- Issue
- 3
- Pages
- 1801587
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- OpenAlex
- W2905932807
- Cited by
- 79
- References
- 35
- Citations by year
- 2026: 7 · 2025: 11 · 2024: 10 · 2023: 11 · 2022: 12 · 2021: 13 · 2020: 8 · 2019: 7
- FWCI
- 5.27
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- European Respiratory Journal (publishedVersion)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- INFM-OAR (INFN Catania) (submittedVersion, other-oa)
- Funders
- F. Hoffmann-La Roche
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
- Keywords
- idiopathic pulmonary fibrosis, comorbidities, survival prediction, mortality risk, gap model, prediction model discrimination, continuous model
- MeSH terms
- Aged, Female, Humans, Male, Middle Aged, Respiratory Function Tests, Retrospective Studies, Models, Statistical, Comorbidity, Survival Analysis, Risk Assessment, Internationality, Idiopathic Pulmonary Fibrosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.